Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819
Go back to Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.06 +0.09 (4.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.97 | 52 Week High | $4.76 | |||
| Open | $2.00 | 52 Week Low | $1.46 | |||
| Day High | $2.16 | P/E | N/A | |||
| Day Low | $1.93 | EPS | $-1.91 | |||
| Volume | 4,697,555 | |||||
